PHARMA JACK

Active Private limited companyfounded 2005active for 21 yearsRue des Preys 84, 6061 CharleroiKBO/BCE: BE 0875.221.694

PHARMA JACK

Financial year 2025

Follow Report Compare

Annual accounts 2025

abbreviated format, filed on 13-08-2026, 13 days late

€375,987

▲ 25.4%

€86,229

▲ 287%

€50,320

▲ 887%

€96,536

▼ 27.0%

9.2%

▼ 4.3 percentage points

1.31

▼ 0.21

The turnover shown is an estimate from the gross margin.

Turnover ≈ €1.3m. Estimated: probably between €1.0m and €2.1m.

Balance sheet

balance sheet total €604,334 on 31-12-2025

What the company ownsHow it is paid for

in euro

Position in the sector

Compare with sector

9.2%

Higher than 20% of 12,856 companies in 2025.

1.31

Higher than 41% of 12,646 companies in 2025.

8.3%

Higher than 67% of 12,719 companies in 2025.

PHARMA JACK Middle half of the sector 80% of the sector Abbreviated accounts in retail trade (NACE 47)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half · Staff: middle half

Staff

€55,349

Staff costs divided by the average number of full-time equivalents.

+1 person

people who joined people who left

In 2025, 2 people joined and 1 left.

Filed annual accounts

as filed with the National Bank, click a year to choose it

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Balance sheet: assets
`20/58`	604,334	606,935	552,122	558,121	606,215	618,656	656,331	668,709	718,879	748,249	804,405	1.0m	405,333	374,670	380,327	306,638	311,847	303,715	335,713	331,301
`21/28`	197,919	223,704	213,996	262,911	293,050	353,941	403,008	452,045	502,196	553,745	601,272	674,967	244,237	182,372	193,109	152,425	173,621	192,935	213,249	234,764
`21`	-	-	-	-	-	-	-	-	180	760	1,340	9,436	21,340	34,144	46,948	59,752	72,556	85,360	98,164	110,968
`22/27`	197,919	223,704	213,996	262,911	293,050	353,941	403,008	452,045	502,016	552,985	599,932	665,531	222,897	148,228	146,161	92,673	101,065	107,575	115,085	123,796
`22`	135,725	162,849	189,964	217,078	244,193	286,707	315,361	344,016	372,670	401,325	429,979	513,893	112,595	128,907	123,137	63,553	65,581	67,609	69,637	71,666
`23`	23,997	12,228	16,891	27,132	20,759	30,029	39,299	47,671	56,780	66,021	75,298	52,269	9,343	6,289	4,704	5,515	6,326	5,122	4,830	3,923
`24`	10,803	13,642	7,141	18,701	28,098	37,205	48,347	60,358	72,565	85,639	94,655	99,369	8,226	13,033	18,319	23,605	29,158	34,844	37,971	42,914
`25`	27,395	34,985	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`27`	-	-	-	-	-	-	-	-	-	-	-	-	92,734	-	-	-	-	-	-	-
`29/58`	406,416	383,230	338,126	295,211	313,165	264,714	253,323	216,664	216,684	194,504	203,132	365,952	161,096	192,298	187,218	154,214	138,226	110,780	122,464	96,536
`3`	158,885	157,523	157,087	133,227	135,300	135,098	143,224	126,811	128,441	114,703	112,996	118,463	71,488	73,813	67,933	59,440	57,821	45,143	47,997	43,770
`30/36`	158,885	157,523	157,087	133,227	135,300	135,098	143,224	126,811	128,441	114,703	112,996	118,463	71,488	73,813	67,933	59,440	57,821	45,143	47,997	43,770
`40/41`	148,309	115,720	98,303	89,986	88,468	66,391	54,700	49,034	52,342	49,354	80,598	141,669	45,305	41,793	39,022	38,544	27,485	33,083	51,463	45,597
`40`	128,180	95,383	79,898	68,651	71,460	59,104	50,725	49,034	52,338	49,352	80,598	139,590	37,495	25,770	32,477	31,569	25,026	31,037	21,184	19,583
`41`	20,128	20,337	18,405	21,335	17,009	7,287	3,974	-	5	2	-	2,079	7,810	16,023	6,545	6,975	2,458	2,047	30,279	26,014
`54/58`	98,744	107,563	79,765	70,207	83,427	60,163	53,242	40,819	35,228	20,448	7,833	105,820	43,767	75,327	80,263	56,230	52,919	32,554	23,004	7,169
`490/1`	478	2,424	2,971	1,791	5,970	3,063	2,158	-	672	10,000	1,705	-	536	1,365	-	-	-	-	-	-
Balance sheet: equity and liabilities
`10/49`	604,334	606,935	552,122	558,121	606,215	618,656	656,331	668,709	718,879	748,249	804,405	1.0m	405,333	374,670	380,327	306,638	311,847	303,715	335,713	331,301
`10/15`	55,519	81,567	90,214	80,059	75,612	37,524	39,218	-11,057	-6,790	-36,468	-29,980	2,253	43,827	36,394	33,813	31,618	35,357	35,771	21,588	8,254
`10/11`	100	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300	6,300
`100`	-	-	-	-	-	-	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600
`101`	-	-	-	-	-	-	12,300	12,300	12,300	12,300	12,300	12,300	12,300	12,300	12,300	12,300	12,300	12,300	12,300	12,300
`13`	55,419	6,959	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860
`130/1`	-	-	-	-	1,860	1,860	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`130`	-	-	-	-	-	-	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860
`1311`	-	-	-	-	1,860	1,860	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`133`	55,419	6,959	1,860	1,860	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`14`	-	68,308	82,054	71,899	67,452	29,364	31,058	-19,217	-14,950	-44,628	-38,140	-5,907	35,667	28,234	25,653	23,458	27,197	27,611	13,428	94
`16`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000
`160/5`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000
`17/49`	548,815	525,367	461,908	478,062	530,603	581,132	617,112	679,766	725,670	784,717	834,384	1.0m	361,506	338,276	346,514	275,021	276,490	267,945	314,125	322,047
`17`	236,210	271,004	272,543	308,262	349,957	392,075	433,044	483,859	538,802	592,374	644,613	746,523	194,218	216,831	238,619	195,746	211,481	226,608	241,150	258,047
`170/4`	236,210	271,004	272,543	308,262	349,957	392,075	433,044	483,859	538,802	592,374	644,613	746,523	194,218	216,831	238,619	195,746	211,481	226,608	241,150	258,047
`42/48`	309,880	251,077	188,733	169,097	179,369	188,190	183,104	194,838	186,868	192,343	189,772	288,924	165,267	119,422	105,871	79,275	62,981	41,337	72,975	64,000
`42`	34,702	38,336	38,836	44,726	45,068	43,838	54,968	58,994	53,572	52,238	51,047	51,695	22,613	21,787	20,992	15,735	15,127	14,542	16,897	16,007
`43`	-	-	-	-	10,000	9,173	-	-	-	3,324	-	-	-	-	5,021	5,018	-	-	30,024	25,000
`430/8`	-	-	-	-	10,000	9,173	-	-	-	3,324	-	-	-	-	5,021	5,018	-	-	30,024	25,000
`44`	119,403	128,745	80,555	62,200	70,121	69,627	77,821	71,718	59,058	57,627	89,681	159,834	33,691	45,195	27,646	20,727	19,977	18,253	17,387	14,699
`440/4`	119,403	128,745	80,555	62,200	70,121	69,627	77,821	71,718	59,058	57,627	89,681	159,834	33,691	45,195	27,646	20,727	19,977	18,253	17,387	14,699
`45`	70,980	63,662	66,596	43,830	50,446	30,391	31,377	35,632	24,300	27,799	18,898	15,622	6,168	8,650	12,346	12,831	10,492	7,458	7,986	5,076
`450/3`	31,195	13,513	30,704	10,223	16,759	7,651	8,991	8,375	4,317	6,270	6,116	8,303	529	425	1,200	4,149	3,595	651	1,719	1,235
`454/9`	39,784	50,150	35,892	33,607	33,687	22,740	22,386	27,257	19,983	21,528	12,782	7,319	5,639	8,225	11,147	8,682	6,897	6,807	6,266	3,840
`47/48`	84,795	20,334	2,746	18,341	3,733	35,161	18,938	28,494	49,938	51,355	30,146	61,773	102,795	43,790	39,867	24,963	17,386	1,083	680	3,218
`492/3`	2,726	3,286	632	703	1,278	866	965	1,069	-	-	-	3,220	2,021	2,023	2,024	-	2,028	-	-	-
Income statement
`76A`	-	-	-	-	22,803	-	-	-	-	-	-	-	460	-	-	-	-	-	-	-
`9900`	375,987	299,793	294,304	270,987	276,845	205,021	270,897	208,169	225,258	194,522	161,265	106,357	90,509	92,787	94,564	90,240	90,674	87,281	73,860	85,595
`62`	249,068	236,469	218,072	201,199	164,726	138,472	145,472	146,747	125,068	128,333	105,024	54,613	42,531	50,558	32,092	33,706	28,580	28,955	22,709	18,549
`630`	40,098	37,945	48,915	48,896	47,740	49,066	50,142	50,151	53,043	53,739	63,544	67,719	25,672	25,830	24,172	21,196	21,714	24,201	23,572	44,654
`640/8`	593	3,078	279	646	26	26	0	101	1	52	389	-	100	100	-	-	-	-	91	40
`66A`	-	-	-	-	-	-	-	-	-	-	439	-	-	-	-	-	-	-	-	-
`9901`	86,229	22,301	27,038	20,246	64,353	17,456	75,284	11,170	47,147	12,398	-7,693	-15,974	22,206	16,298	38,300	35,337	40,380	34,125	27,488	22,353
`75/76B`	206	224	39	53	99	-	6	12	4	1	112	290	369	1,033	386	240	166	131	5,152	7
`75`	206	224	39	53	99	-	6	12	4	1	112	290	369	1,033	386	240	166	131	5,152	7
`65/66B`	13,614	11,988	9,124	11,407	12,991	16,438	13,989	15,200	17,191	18,761	24,083	25,750	12,452	13,043	11,400	10,036	10,479	13,249	14,344	19,521
`65`	13,614	11,988	9,124	11,407	12,991	16,438	13,989	15,200	17,191	18,761	24,083	25,750	12,452	13,043	11,400	10,036	10,479	13,249	14,344	19,521
`9903`	72,821	10,537	17,952	8,893	51,461	1,018	61,301	-4,019	29,960	-6,363	-32,103	-41,434	10,583	4,288	27,285	25,542	30,067	21,006	18,295	2,839
`67/77`	22,501	5,438	7,797	4,445	13,373	2,713	11,026	248	282	125	130	141	3,150	1,706	10,090	9,281	10,481	6,023	4,161	885
`9904`	50,320	5,099	10,155	4,448	38,088	-1,695	50,275	-4,267	29,678	-6,488	-32,233	-41,574	7,433	2,582	17,195	16,261	19,586	14,983	14,134	1,954
`9905`	50,320	5,099	10,155	4,448	38,088	-1,695	50,275	-4,267	29,678	-6,488	-32,233	-41,574	7,433	2,582	17,195	16,261	19,586	14,983	14,134	1,954
Appropriation of the result
`9906`	118,628	87,154	82,054	71,899	67,452	29,364	31,058	-19,217	-14,950	-44,628	-38,140	-5,907	35,667	28,234	40,653	43,458	47,197	28,411	14,228	1,954
`14P`	68,308	82,054	71,899	67,452	29,364	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`791/2`	1,860	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`691/2`	50,320	5,099	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,860
`6920`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,860
`6921`	50,320	5,099	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`694/7`	70,168	13,746	-	-	-	-	-	-	-	-	-	-	-	-	15,000	20,000	20,000	800	800	-
`694`	70,168	13,746	-	-	-	-	-	-	-	-	-	-	-	-	15,000	20,000	20,000	800	800	-
Social balance sheet
`9087`	4.5	4.3	4.5	4.7	4	3.8	3.6	3.4	2.9	2.8	2.9	2.1	1	1	0.8	0.8	0.7	0.8	0.4	0.2
Hours worked`1013`	1,896	8,273	8,015	7,846	7,050	6,189	6,618	6,457	5,656	5,761	4,758	2,716	1,978	2,116	1,552	1,648	1,488	1,539	1,017	616
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

The notes to these accounts have 10 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 13-08-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 13 days after the deadline. Filed on 13 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00399578.

Financial year	Type	Filed	Reference	Document
31-12-2025	abbreviated format	13-08-2026	2026-00399578	PDF
31-12-2024	full format	29-08-2025	2025-00462163	PDF
31-12-2023	full format	23-08-2024	2024-00362367	PDF
31-12-2022	full format	30-08-2023	2023-00378343	PDF
31-12-2021	full format	23-09-2022	2022-20434070	PDF
31-12-2020	full format	30-08-2021	2021-61800208	PDF
31-12-2019	full format	27-08-2020	2020-46000003	PDF
31-12-2018	full format	02-09-2019	2019-63000352	PDF
31-12-2017	full format	29-06-2018	2018-28400312	PDF
31-12-2016	full format	07-08-2017	2017-43000330	PDF
31-12-2015	full format	29-08-2016	2016-50400221	PDF
31-12-2014	full format	12-08-2015	2015-42000089	PDF
31-12-2013	full format	07-08-2014	2014-41900141	PDF
31-12-2012	full format	30-08-2013	2013-56900309	PDF
31-12-2011	full format	17-08-2012	2012-42200268	PDF
31-12-2010	full format	15-07-2011	2011-31100341	PDF
31-12-2009	full format	01-09-2010	2010-53500452	PDF
31-12-2008	full format	26-08-2009	2009-69800356	PDF
31-12-2007	full format	25-08-2008	2008-63800223	PDF
31-12-2006	full format	29-08-2007	2007-70800321	PDF

Key figures and ratios

per financial year, computed from the annual accounts

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
126,326	60,247	75,953	69,142	112,093	66,523	125,425	61,321	100,189	66,137	55,852	51,744	47,878	42,128	62,472	56,534	62,094	58,325	51,060	67,007
90,417	43,045	59,070	53,344	85,828	47,372	100,417	45,884	82,720	47,251	31,312	26,145	33,105	28,412	41,367	37,457	41,300	39,183	37,707	46,608
14,312	47,654	0	18,757	2,249	0	1,104	0	1,493	6,212	45,289	498,448	87,077	15,094	64,856	0	2,400	3,887	2,057	279,418
-8,819	27,798	9,558	-13,220	23,264	6,921	12,423	5,591	14,781	12,615	-97,987	62,053	-31,560	-4,936	24,033	3,310	20,366	9,550	15,834	-
96,536	132,153	149,393	126,114	133,796	76,524	70,220	21,826	29,816	2,161	13,361	77,028	-4,172	72,876	81,347	74,938	75,244	69,443	49,489	32,537
9.2%	13.4%	16.3%	14.3%	12.5%	6.1%	6.0%	-1.7%	-0.9%	-4.9%	-3.7%	0.2%	10.8%	9.7%	8.9%	10.3%	11.3%	11.8%	6.4%	2.5%
1.31	1.53	1.79	1.75	1.75	1.41	1.38	1.11	1.16	1.01	1.07	1.27	0.97	1.61	1.77	1.95	2.19	2.68	1.68	1.51
0.80	0.90	0.96	0.96	0.99	0.69	0.60	0.46	0.47	0.41	0.47	0.86	0.54	0.99	1.13	1.20	1.28	1.59	1.02	0.82
9.89	6.44	5.12	5.97	7.02	15.49	15.74	-	-	-	-	-	8.25	9.29	10.25	8.70	7.82	7.49	14.55	39.02
90.6%	6.3%	11.3%	5.6%	50.4%	-4.5%	128.2%	-	-	-	-	-	17.0%	7.1%	50.9%	51.4%	55.4%	41.9%	65.5%	23.7%
8.3%	0.8%	1.8%	0.8%	6.3%	-0.3%	7.7%	-0.6%	4.1%	-0.9%	-4.0%	-4.0%	1.8%	0.7%	4.5%	5.3%	6.3%	4.9%	4.2%	0.6%
9.28	5.03	8.32	6.06	8.63	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item	31-12-2025	31-12-2024	31-12-2023	31-12-2022	31-12-2021
Employees at the balance-sheet date	7	6	7	7	5
full-time	2	1	1	1	1
part-time	5	5	6	6	4
in full-time equivalents	4.5	4.1	4.8	5	4
	4.2	4.3	4.5	4.7	4
On a permanent contract	6	5	5	5	5
Joined	2	7	5	7	-
Left	1	6	5	5	-

Source: social balance sheet in the 2021 to 2025 annual accounts

Investments

fixed assets acquired

Item	2025	2024	2023	2022	2021
Tangible fixed assets	€14,312	€47,654	-	€18,757	€2,249
	€40,098	€37,945	€48,915	€48,896	€47,740

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on PHARMA JACK

The operating result for 2025 is nearly 3.9 times that of 2024 and the highest since 2006. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total rises from 86.6% to 90.8%. Equity is lower and debt is higher.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency9.2%

Current ratio1.31

Return on assets8.3%

Staff

Staff cost per FTE€55,349

Joined and left+1 person

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on PHARMA JACK

Next steps

in euro

in euro

9.2%

1.31

8.3%

€55,349

+1 person